‌

US Patent 11878958 MEK inhibitors and uses thereof

Patent 11878958 was granted and assigned to Ikena Oncology on January, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Patent Applicant

Ikena Oncology

Current Assignee

Ikena Oncology

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

118789580

Patent Inventor Names

Alfredo C. Castro0

Sabine K. Ruppel0

Thomas A. Wynn0

Sergio L. Santillana Soto0

Eric Haines0

Lan Xu0

Michael J. Burke0

Oksana Zavidij0

Date of Patent

January 23, 2024

Patent Application Number

183237000

Date Filed

May 25, 2023

Patent Citations

‌

US Patent 8889638 Stimulus-triggered prodrugs

Patent Primary Examiner

CPC Code

Patent abstract

The present disclosure provides MEK inhibitors, compositions thereof, and methods of using the same.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11878958 MEK inhibitors and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API